Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

In this Phase II trial (n=247), once-weekly insulin icodec resulted in a similar change in HbA1c from baseline to week 26 as once-daily insulin glargine U100 (estimated between-group difference of −0.18 percentage points [95% CI –0.38 to 0.02], P=0.08).

Source:

New England Journal of Medicine